Marcos Giron, right, poses with Novak Djokovic last year in Los Angeles. Photo courtesy of Brener Zwikel & Assoc. |
Giron, 26, was diagnosed with cellulitis (a bacterial skin infection), according to USTA supervisor Keith Crossland. Further details were not available.
Giron, the 2014 NCAA singles champion from UCLA, has soared from No. 308 at the end of last year to No. 126. He reached the third round of the prestigious BNP Paribas Open in Indian Wells in March, beating then-No. 24 Alex de Minaur and then-No. 37 Jeremy Chardy.
Giron, only 5-foot-11 (1.80 meters) and 170 pounds (77 kilograms), also made his first two appearances in the main draw of a Grand Slam tournament this year. He lost in the opening round at Wimbledon as a qualifier and the U.S. Open as a wild card.
Donald Young, a 30-year-old left-hander who has won four Challenger singles titles in Northern California, took Giron's place in the Fairfield draw as the 17th seed. Young has tumbled from a career-high No. 38 in 2012 to No. 233.
Strong Kirchheimer, a 24-year-old former Northwestern star from Cary, N.C., moved into Young's former spot as an alternate.
In the first match of the main draw on Monday at 11 a.m., Collin Altamirano of Sacramento is scheduled to play wild card Brandon Holt, a USC senior and the son of International Tennis Hall of Famer Tracy Austin. Holt has not lost a set to Altamirano in two career meetings, although one went to a tiebreaker.
Another wild card, 16-year-old Zachary Svajda of San Diego, will meet 6-foot-8 (2.03-meter) Michael Redlicki, a 25-year-old Chicago native. Svajda won the USTA boys 18 singles title in August to earn an automatic wild card in the U.S. Open and extended Paolo Lorenzi, a 37-year-old Italian, to five sets in the opening round.
In a final-round qualifying match, Dennis Novikov, a 25-year-old San Jose product, will face Sem Verbeek, a former University of the Pacific star from the Netherlands, at 10 a.m.
Here are the Fairfield singles and doubles draws and Monday's schedule. Live streaming is available.
No comments:
Post a Comment